Close Menu

PALO ALTO, Calif.--Incyte Pharmaceuticals said it has finalized an agreement to contribute to the Human Genome Project by performing DNA sequencing for the University of Washington. The university, which named Incyte as a collaborator in a grant proposal it made to the US National Human Genome Research Institute earlier this year, will refine the data Incyte generates and deposit it to GenBank. The university had requested $3 million to budget for Incyte’s sequencing services.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.